PROMACTA (eltrombopag olamine)

**Product type:** Human Prescription Drug

**Active ingredient:** ELTROMBOPAG OLAMINE

**Strength:** 12.5 mg/1

**Dosage form:** Powder, For Suspension

**Route:** Oral

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** NDA (NDA207027)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]